A phase 2, multi-stage, multi-center trial exploring the safety and efficacy of AG-014699 in subjects with diffuse diabetic macular edema (DME) involving the center of the retina

Trial Profile

A phase 2, multi-stage, multi-center trial exploring the safety and efficacy of AG-014699 in subjects with diffuse diabetic macular edema (DME) involving the center of the retina

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 07 May 2015

At a glance

  • Drugs Rucaparib (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 16 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top